Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- Mice Model Market, By Type
5.1 Introduction
5.2 Inbred Mice
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Outbred Mice
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Genetically Engineered Mice
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Hybrid/Congenic Mice
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Others
5.6.1 Market Overview
5.6.2 Market Size and Forecast
- Mice Model Market, By Technology
6.1 Introduction
6.2 CRISPR/CAS9
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Embryonic Stem Cell Injection
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Nuclear Transfer
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Other Technologies
6.5.1 Market Overview
6.5.2 Market Size and Forecast
- Mice Model Market, By Application
7.1 Introduction
7.2 Oncology
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Cardiovascular Studies
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Neurology
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Other Applications
7.5.1 Market Overview
7.5.2 Market Size and Forecast
- Mice Model Market, By Service
8.1 Introduction
8.2 Breeding
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Cryopreservation
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Model in-Licensing
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Genetic Testing
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Other Services
8.6.1 Market Overview
8.6.2 Market Size and Forecast
- Mice Model Market, By Geography
9.1 Introduction
9.2 Europe
9.2.1 Europe Mice Model, By Type
9.2.2 Europe Mice Model, By Technology
9.2.3 Europe Mice Model, By Application
9.2.4 Europe Mice Model, By Service
9.3 North America
9.3.1 North America Mice Model, By Type
9.3.2 North America Mice Model, By Technology
9.3.3 North America Mice Model, By Application
9.3.4 North America Mice Model, By Service
9.4 Asia Pacific
9.4.1 Asia Pacific Mice Model, By Type
9.4.2 Asia Pacific Mice Model, By Technology
9.4.3 Asia Pacific Mice Model, By Application
9.4.4 Asia Pacific Mice Model, By Service
9.5 Rest of The World
9.5.1 Rest of The World Mice Model, By Type
9.5.2 Rest of The World Mice Model, By Technology
9.5.3 Rest of The World Mice Model, By Application
9.5.4 Rest of The World Mice Model, By Service
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
11.1 Taconic Biosciences, Inc.
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 The Jackson Laboratory
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Charles River Laboratories
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Ingenious Targeting Laboratory
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 JANVIER LABS
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 TransCure bioservices
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Envigo
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 genOway
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 PolyGene
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Crown Biosciences
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments